BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37703536)

  • 41. Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer.
    Park SY; Lee JG; Kim J; Byun GE; Bae MK; Lee CY; Kim DJ; Chung KY
    J Cardiothorac Surg; 2013 Jun; 8():151. PubMed ID: 23759129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.
    Yang F; Gao L; Wang Q; Gao W
    Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
    Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
    BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
    Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
    Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lobe-specific analysis of perioperative chemotherapy for non-small cell lung cancer patients.
    Lei X; Li T; Mao F; Ren F; Tang Q; Cao W; Zu L; Xu S
    Cancer Med; 2023 Aug; 12(16):16896-16905. PubMed ID: 37403701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of nomograms to predict early death in non-small cell lung cancer patients with brain metastasis: a retrospective study in the SEER database.
    Yang F; Gao L; Wang Q; Gao W
    Transl Cancer Res; 2023 Mar; 12(3):473-489. PubMed ID: 37033346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
    Felip E; Altorki N; Zhou C; Csőszi T; Vynnychenko I; Goloborodko O; Luft A; Akopov A; Martinez-Marti A; Kenmotsu H; Chen YM; Chella A; Sugawara S; Voong D; Wu F; Yi J; Deng Y; McCleland M; Bennett E; Gitlitz B; Wakelee H;
    Lancet; 2021 Oct; 398(10308):1344-1357. PubMed ID: 34555333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy?
    Wang Y; Guo S; Zhang J; Meng XY; Zheng ZC; Zhao Y
    Scand J Gastroenterol; 2020 Feb; 55(2):193-201. PubMed ID: 31976783
    [No Abstract]   [Full Text] [Related]  

  • 49. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
    Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database.
    Wang J; Tang J; Liu X; He D
    BMC Urol; 2022 May; 22(1):78. PubMed ID: 35610606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.
    Sun H; Liu M; Yang X; Ren Y; Dai H; Wang C
    Clin Respir J; 2022 May; 16(5):380-393. PubMed ID: 35514033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative adjuvant therapy for stage IB non-small-cell lung cancer.
    Mineo TC; Ambrogi V; Corsaro V; Roselli M
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):378-84. PubMed ID: 11463561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel nomogram for predicting long-term heart-disease specific survival among older female primary breast cancer patients that underwent chemotherapy: A real-world data retrospective cohort study.
    Huang C; Ding Z; Li H; Zhou Z; Yu M
    Front Public Health; 2022; 10():964609. PubMed ID: 36091523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H; Toyooka S
    Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer.
    Rajaram R; Paruch JL; Mohanty S; Holl JL; Bilimoria KY; Ko CY; Winchester DP; Patel JD; DeCamp MM
    Ann Thorac Surg; 2016 Feb; 101(2):533-40. PubMed ID: 26507427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer.
    Huang X; Hu P; Yan F; Zhang J
    Technol Cancer Res Treat; 2022; 21():15330338221074506. PubMed ID: 35060800
    [No Abstract]   [Full Text] [Related]  

  • 58. Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA.
    Lee JM; Wang R; Johnson A; Ogale S; Kent M; Lee JS
    Future Oncol; 2023 Jan; 19(1):37-47. PubMed ID: 36662515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
    Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
    Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.